Page 1

Bio - Gate AG Bio - Gate AG reports first half results for 2026 Corporate | 9 October 2026 15:55 Bio - Gate AG / Key word ( s ) : Half Year Results Bio - Gate AG reports first half results for 2026 09.10.2026 / 15:55 CET / CEST The issuer is solely responsible for the content of this announcement . PRESS RELEASE Bio - Gate AG Reports First - Half Results for 2026 First - half revenue of 2.8 million euros , down from the previous year ( 3.4 million euros ) ⚫ EBIT loss of 927 TEUR ; cost - saving measures taking effect • Forecasts for full - year 2026 revenue and earnings adjusted • Revenue growth in the Veterinary and Measurement Technology ; Derma - Cosmetics and Wound Care business segment with a temporary decline in revenue Nuremberg / Bremen , October 9 , 2026 - Bio - Gate AG ( ISIN DE000BGAG981 ) , a leading provider of proprietary antimicrobial technologies for human and veterinary medicine , generated consolidated revenue of 2.8 million euros in the first half of 2026 ( as of June 30 ) , a decline of just under 18 percent compared to the same period last year . Changes in the product portfolio and organizational restructuring ―particularly in the derma - cosmetics and wound care business segments - led to significantly lower order volumes from two major customers for human and animal care products , respectively . The medical technology segment , which includes implant coatings , performed in line with expectations . However , revenue growth was weaker due to timing shifts related to specific dates in the completion of milestones . This was caused by delayed partial deliveries from a project partner . By contrast , the Veterinary and Measurement Services business segments increased their revenue contributions . At the half - year mark , Bio - Gate reported a loss of 814 TEUR at the EBITDA level ( previous year : -723 TEUR ) and a loss of 927 TEUR at the EBIT level ( previous year : -840 TEUR ) . As a result , the losses — relative to the decline in revenue — were significantly lower due to positive effects from cost - saving and efficiency measures already implemented .